Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 36 (3) , 345-349
- https://doi.org/10.1016/0167-5273(92)90305-m
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.Heart, 1990
- Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk.Circulation, 1989
- Importance of lead selection in QT interval measurementThe American Journal of Cardiology, 1988
- Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave.Circulation, 1987
- Mapping of body surface potentials in patients with the idiopathic long QT syndrome.Circulation, 1986
- Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.Heart, 1985
- Spatial variation of QT intervals in normal persons and patients with acute myocardial infarctionJournal of the American College of Cardiology, 1985
- QT interval variability on the body surfaceJournal of Electrocardiology, 1984
- Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations.Circulation, 1983
- QT interval prolongation as predictor of sudden death in patients with myocardial infarction.Circulation, 1978